D J Balestra, B Littenberg. Show Affiliations »
Abstract
Mesh: See more » AdultAgedCost-Benefit AnalysisHumansMiddle AgedTetanus/economicsTetanus/prevention & controlTetanus Toxoid/administration & dosageTetanus Toxoid/economicsVaccination/economicsVaccination/standards
Substances: See more » Tetanus Toxoid
Year: 1994 PMID: 7990239 DOI: 10.1001/jama.272.24.1900
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272